<DOC>
	<DOCNO>NCT01830348</DOCNO>
	<brief_summary>The purpose study determine DSC127 effective increase incidence complete wound closure 10 week confirm visit 2 week later compare vehicle ( gel without active ingredient ) subject diabetes mellitus ( DM ) chronic Wagner Grade 1 2 plantar neuropathic foot ulcer , 0.75 - 6 cm2 size .</brief_summary>
	<brief_title>Phase III Study Evaluate Efficacy Safety DSC127 Diabetic Foot Ulcers</brief_title>
	<detailed_description>Subjects undergo two week screen period ass plantar ulcer healing , heal less 30 % eligible randomization , provide meet inclusion criterion . Four week blind `` treatment '' follow screen period , observation period six week ( 10 week post first treatment ) follow 4-week treatment period . If ulcer close treatment observation period , closure confirm two week later , time subject enters durability assessment period 12 week . All aspect Standard Care follow throughout study period .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>1 . Male female ambulatory subject age ≥18 year time inform consent 2 . Has type 1 type 2 DM metabolic control confirm glycosylated hemoglobin ( HbA1c ) ≤12 % serum creatinine level ≤3mg/dL 3 . At Screening Baseline ( prior randomization ) , subject least one ulcer fulfills follow criterion : Present ≥1 month ≤1 year Partial full thickness involve bone , tendon , capsule ( probe tendon capsule ) , i.e . Wagner Grade 1 2 Has sign infection osteomyelitis Plantar neuropathic ulcer ; ulcer must predominantly plantar surface foot ensure adequate offloading may include toe Size target ulcer must 0.75 6 cm2 Target ulcer must nonhealing defined &lt; 30 % reduction size response standard care two week Screening Period If one ulcer present meet inclusion criterion , large one consider Target ulcer . If two ulcer size meet criterion , one high Wagner Grade consider Target ulcer . If two ulcer size Wagner Grade , one present long qualifying time Target ulcer . 4 . Has ankle brachial index ( ABI ) ≥ 0.7 foot target ulcer 5 . Has assessment baseline level neuropathy foot use SemmesWeinstein filament . 6 . A female subject childbearing potential must negative serum pregnancy test time Screening , must willing use medically acceptable method birth control , Essure® , hormonal contraception ( oral pill , implantable device , skin patch ) , intrauterine device , tubal ligation , double barrier throughout study . A female subject childbearing potential practice abstinence require employ birth control . 7 . Has ability willingness understand comply study procedure give write informed consent prior enrollment study initiation study procedures 1 . Has know hypersensitivity investigational drug vehicle component 2 . Has expose investigational agent within 30 day entry study 3 . A female pregnant nursing 4 . Has active malignant disease kind except basal cell carcinoma ( skin ) . A subject , malignant disease past , treat currently diseasefree , may consider study entry . 5 . Has hemoglobin le 8.5 gm/dL . 6 . Transaminase level great 3 × normal 7 . Is receive hemodialysis chronic ambulatory peritoneal dialysis ( CAPD ) therapy 8 . Has prior radiation therapy part foot target ulcer study 9 . Use systemic corticosteroid immunosuppressant ( within 8 week prior screen ) 10 . Has ulcer primarily ischemic etiology 11 . Has sicklecell anemia , Reynaud 's , peripheral vascular disease 12 . Has receive biologic agent , growth factor skin equivalent ( Regranex® , Apligraft , Dermagraft ) , past 30 day 13 . Has target ulcer determine clinically infect require antimicrobial . Any antibiotic therapy must complete discontinued screening . 14 . Has Wagner Grade 3 great DFU , deep abscess , gangrene 15 . Has uncontrolled hypertension , opinion Investigator . 16 . Any finding , opinion Investigator , may interfere assessment product participation subject study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>diabetic foot ulcer</keyword>
	<keyword>Wagner Grade 1 2 foot ulcer</keyword>
</DOC>